Task: Answer the multiple choice question.
Question: Which compound exhibits a -56.979% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a COc1ccc(CCC(=O)Nc2nc3ccccc3[nH]2)cc1OC
b CCOC(=O)C1(CC2CC2)CCN(Cc2ccc(C(=O)OC)cc2)CC1
c CC(=O)/C=C(\C)Nc1ccccc1O
Answer: b. CCOC(=O)C1(CC2CC2)CCN(Cc2ccc(C(=O)OC)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)C1(CC2CC2)CCN(Cc2ccc(C(=O)OC)cc2)CC1
CCOC(=O)C1(CC2CC2)CCN(Cc2ccc(C(=O)OC)cc2)CC1
ethyl 4-(cyclopropylmethyl)-1-[(4-methoxycarbonylphenyl)methyl]piperidine-4-carboxylate